Mitral regurgitation
Also known as: Mitral valve regurgitation, Mitral insufficiency, Mitral valve incompetence, Leaking mitral valve
Mitral regurgitation involves retrograde flow from the left ventricle into the left atrium during ventricular systole, resulting from primary valvular pathology or secondary ventricular remodelling. Clinical management prioritises echocardiographic assessment, longitudinal symptom monitoring, and preservation of ventricular function, with interventions ranging from pharmacological support to surgical repair. Within a TCM context, intervention is restricted to supportive symptom management for medically stable patients and cannot effect structural repair or arrest the progression of heart failure. Current evidence is limited to observational data and case reports, some lacking abstracts; no studies evaluate the efficacy of acupuncture or herbal medicine for this condition. The described patterns represent traditional frameworks rather than validated diagnostic categories. Potential therapeutic benefits are unestablished and must not delay essential cardiological care.
Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.
Lifestyle & Diet
- •Adhere to all scheduled cardiological consultations and echocardiographic assessments, regardless of perceived symptomatic improvement.
- •Maintain a systematic record of functional capacity, instances of dyspnoea or palpitations, and fluctuations in body mass as directed by the treating cardiac team.
- •Strictly follow medical directives concerning physical exertion, sodium intake, and fluid volumes; avoid autonomous adjustments to fluid intake, particularly in the presence of concurrent renal impairment.
- •Maintain oral hygiene and attend regular dental care; consult the treating team regarding whether any procedure-specific precautions apply.
Cautions & Contraindications
- •Defer elective acupuncture and herbal initiation during suspected cardiac decompensation, symptomatic hypotension or unstable palpitations; arrange medical assessment. Source 3 supplies risk context, not evidence for acupuncture contraindications.[]
- •Do not recommend additional fluids, diuretic herbs or changes to prescribed vasodilators or beta-blockers without the cardiac team. The post-TAVI case illustrates context-dependent haemodynamics rather than a general treatment rule for mitral regurgitation.[]
- •In advanced kidney disease or dialysis, obtain renal-team approval before herbal treatment and protect dialysis access from needling. Source 2 supports the need for cardiovascular monitoring in its specific dialysis population; it does not establish herbal or needling safety.[]
When to reassess or seek care again
For medically stable patients choosing adjunctive care, review after 2–4 weeks using baseline and follow-up fatigue and sleep scores, usual walking tolerance, symptom frequency and adverse effects. Review blood pressure and weight only within the medical monitoring plan. Stop or modify adjunctive care if there is no meaningful symptomatic benefit; refer promptly for deterioration or new palpitations. Symptom improvement does not demonstrate reduced regurgitation, and must not change cardiologist-directed imaging intervals.
Explore more diseases
Sources & Further Reading
Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.
- Korean journal of radiology · 2026
- Journal of inflammation research · 2026
- Frontiers in cardiovascular medicine · 2026
- European heart journal. Case reports · 2026
Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.
